BIBLIOGRAPHY
- Alper CA, Rosen FS, Janeway CA: The gamma globulins. II. Hypergammaglobulinemia. N Engl J Med 275: 591–596; 652–659, 1966
- Ballard HS, Hamilton LM, Marcus AJ, et al: A new variant of heavy-chain disease (μ-chain disease). N Engl J Med 282: 1060–1062, 1970
- Burnet FM: Immunological aspects of malignant disease. Lancet 1: 1171–1174, 1967
- Carbone PP, Kellerhouse LE, Gehau EA: Plasmacytic myeloma: A study of the relationship of survival to various clinical manifestations and anomalous protein type in 112 patients. Am J Med 42: 937–948, 1967
- Combined Staff Clinic: Plasma cell dyscrasias: Current clinical and biochemical concepts. Am J Med 44: 256–269, 1968
- Edelman GM, Gall WE: The antibody problem. Ann Rev Biochem 38: 415–466, 1969
- Fahey JL, Barth WF, Solomon A: Serum hyperviscosity syndrome. JAMA 192: 464–467, 1965
- Fahey JL, Carbone PP, Rowe DS, et al: Plasma cell myeloma with D-myeloma protein (IgD myeloma). Am J Med 45: 373–380, 1968
- Franklin EC, Lowenstein J, Bigelow B, et al: Heavy chain disease—a new disorder of serum γ-globulins: Report of the first case. Am J Med 37: 332, 1964
- Freel RJ, Maldonado JE, Gleich GJ: Hyperviscosity syndrome associated with immunoglobulin A myeloma. Am J Med Sci 264: 117–122, 1972
- Hobbs JR: Paraproteins, benign or malignant, Br Med J 3: 699–704, 1967
- Janeway CA, Rosea FS: The gamma globulins. IV. Therapeutic uses of gamma globulin. N Engl J Med 275: 826–831, 1966
- Killander J: Gamma Globulins: Structure and Control of Biosynthesis. New York, Interscience Publishers Inc, 1967
- Kyle RA, Bayrd ED: “Primary” systemic amyloidosis and myeloma: Discussion of relationship and review of 81 cases. Arch Intern Med 107: 344–353, 1961
- Kyle RA, Bayrd ED: “Benign” monoclonal gammopathy: A potentially malignant condition, Am J Med 40: 426–430, 1966
- Maldonado JE, Brown AL Jr, Bayrd ED, et al: Ultrastructure of the myeloma cell. Cancer 19, 1613–1627, 1966
- Maldonado JE, Kyle RA, Brown AL Jr, et al: “Intermediate” cell types and mixed cell proliferation in multiple myeloma: Electron microscopic observations. Blood 27: 212–226, 1966
- McCallister BD, Bayrd ED, Harrison EG Jr, et al: Primary macroglobulihemia: Review with a report on thirty-one cases and notes on the value of continuous chlorambucil therapy. Am J Med 43: 394–434, 1967
- Merler E, Rosen FS: The gamma globulins. I. The structure and synthesis of the immunoglobulins. N Engl J Med 275: 480–486; 536–542, 1966
- Ogawa M, Kochwa S, Smith C, et al: Clinical aspects of IgE myeloma. N Engl J Med 281: 1217–1220, 1969
- Porter RR: The structure of antibodies. Sci Am 217: 81–90, 1967
- Putnam FW: Immunoglobulin structure: Variability and homology. Science 163: 633–644, 1969
- Rosen FS, Janeway CA: The gamma globulins. III. The antibody deficiency syndromes. N Engl J Med 275: 709–715; 769–775, 1966
- Seligmann M; Données récentes sur les immunoglobulines monoclonales. Nouv Rev Fr Hematol 10: 329–334, 1970
- Seligmann M, Mihaesco E, Hurez D, et al: Immunochemical studies in four cases of alpha chain disease. J Clin Invest 48: 2374–2389, 1969
- Tornasi TB Jr: Human immunoglobulin A. N Engl J Med 279: 1327–1330, 1968
- Waldenström J: Studies on conditions associated with disturbed gamma globulin formation (gammopathies). Harvey Lert 56: 211–231, 1961
- Waldenström J: The occurrence of benign, essential monoclonal (M type), non-macromolecular hyperglobulinemia and its differential diagnosis. IV. Studies in the gammopathies. Acta Med Scand 176: 345–365, 1964
- Waldmann TA: Disorders of immunoglobulin metabolism. N Engl J Med 281: 1170–1177, 1969
- Williams RC Jr, Brunning RD, Wollheim FA: Light-chain disease: An abortive variant of multiple myeloma. Ann Intern Med 65: 471–486, 1966
- Zawadski ZA, Edwards GA: Dysimmunoglobulinemia in the absence of clinical features of multiple myeloma and macroglobulinemia. Am J Med 42: 67–88, 1967